NEXT Life Sciences published a coverage article by Laura Simmons of IFLScience discussing clinical study results for Plan A™ for Men and PausePill™ by Founder and Executive Chairman L.R. Fox.
Published
Signal category
Research & Knowledge
Quote
“In their latest coverage, Laura Simmons of IFLScience spoke with our Founder and Executive Chairman, L.R. Fox, about exciting clinical study results for Plan A™ for Men and PausePill™”
— NEXT Life Sciences team
Company
NEXT Life Sciences
NEXT Life Sciences is advancing a pipeline of de-risked and transformative reproductive & sexual health products.
- Industry
- Biotechnology Research
- Company size
- 19 employees
NEXT Life Sciences is a reproductive health platform company advancing a portfolio of medical device and pharmaceutical products designed to address significant unmet needs in reproductive and sexual health. Along with other reproductive products, the company’s two lead male contraceptives are Plan A™, a long-acting, non-hormonal, and reversible on-demand male contraceptive, and PausePill™, an on-demand, non-hormonal male contraceptive pill. For more information, visit nextlifesciences.org and planaformen.com
Founded 2020